Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1-Reference-Cited by-同舟云学术

Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1

Published:2016-09-29 Issue:9 Volume:11 Page:e0163884
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ide Tatsuya^ORCID,Eguchi Yuichiro,Harada Masaru,Ishii Kunihide,Morita Masaru,Morita Yasuyo,Sugiyama Gen,Fukushima Hirofumi,Yano Yoichi,Noguchi Kazunori,Nakamura Hiroki,Hisatomi Junjiro,Kumemura Hiroto,Shirachi Miki,Iwane Shinji,Okada Michiaki,Honma Yuichi,Arinaga-Hino Teruko,Miyajima Ichiro,Ogata Kei,Kuwahara Reiichiro,Amano Keisuke,Kawaguchi Toshihiro,Kuromatsu Ryoko,Torimura Takuji,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Natural history of chronic hepatitis C;LB Seeff;Hepatology,2002

2. New antiviral therapies for chronic hepatitis C;T Kanda;Hepatol Int,2010

3. Telaprevir for previously untreated chronic hepatitis C virus infection;IM Jacobson;N Engl J Med,2011

4. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study;MW Fried;Hepatology,2013

5. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study;M Manns;Lancet,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis;Journal of Hepatology;2019-09

2. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?;World Journal of Hepatology;2018-09-27

3. Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan;Journal of Gastroenterology;2018-05-08

4. Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia;Alimentary Pharmacology & Therapeutics;2018-01-12

5. Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93;Journal of Medical Virology;2017-12-28